Blood marker may spot hidden fungal infections in ICU patients

NCT ID NCT03140748

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether a substance called β-D-glucan in the blood can help identify and track fungal infections in the abdomen (peritonitis) in intensive care patients. Researchers measured levels in 70 adults with peritonitis, comparing those with and without Candida yeast. The goal was to see if this blood test could aid diagnosis and monitor treatment response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that measuring β-D-glucan in the blood helps doctors diagnose and monitor fungal peritonitis, potentially improving treatment decisions.

What could go wrong

This is a small, observational study with only 70 participants. It does not test a treatment, so it may not lead to any direct patient benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANDIDA INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

candidiasis infectious peritonitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, Picardie, 80054, France